Top

Canntab Therapeutics

Canadian Securities Exchange (CNSX) | Nov 11, 2019, 8:55 PM EST

PILL:CNX $ 0.50
CHANGE
000 (000%)
VOLUME
1,524
Day Low: 0.00
Day High: 0.00
Detailed Quote
Open: 000
High: 000
Low: 000
Prev. Close: 0.50
Beta: -1.4482
Bid: 0.46
Bid Size: 4
Ask: 0.49
Ask Size: 2
VWAP: N/A
Shares Out.: 25,306,601
Total Shares (All Classes)2: 25,306,601
Market Cap1: 12,653,301
Market Cap (All Classes)2*: 12,653,301
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
EPS: -0.10
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: 7.143
Exchange: CSE

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.

Description

Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use. More

Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.